[
  {
    "ts": "2026-02-05T08:00:00+00:00",
    "headline": "Exclusive: Lawhive, a startup using AI to reimagine the general practice law firm, raises $60 million in new venture capital funding",
    "summary": "The startup offers routine legal services using human lawyers assisted by AI software.",
    "url": "https://finance.yahoo.com/news/exclusive-lawhive-startup-using-ai-080000322.html",
    "source": "Fortune",
    "provider": "yfinance",
    "raw": {
      "id": "2e2e0eb9-a311-3052-8037-64e09064e515",
      "content": {
        "id": "2e2e0eb9-a311-3052-8037-64e09064e515",
        "contentType": "STORY",
        "title": "Exclusive: Lawhive, a startup using AI to reimagine the general practice law firm, raises $60 million in new venture capital funding",
        "description": "",
        "summary": "The startup offers routine legal services using human lawyers assisted by AI software.",
        "pubDate": "2026-02-05T08:00:00Z",
        "displayTime": "2026-02-05T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/fortune_175/a1f6d1f9ae7a37d9e39b10b48eb1d447",
          "originalWidth": 2048,
          "originalHeight": 1365,
          "caption": "Lawhive cofounders Flinn Dolman (left), Pierre Proner (center), and Jaime Van Oers.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DTmWUJEcC_ScHUisSFCJfQ--~B/aD0xMzY1O3c9MjA0ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/fortune_175/a1f6d1f9ae7a37d9e39b10b48eb1d447.cf.webp",
              "width": 2048,
              "height": 1365,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/p0rjUjmcBZwU7gXudhg_wg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/fortune_175/a1f6d1f9ae7a37d9e39b10b48eb1d447.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Fortune",
          "url": "http://fortune.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/exclusive-lawhive-startup-using-ai-080000322.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/exclusive-lawhive-startup-using-ai-080000322.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T15:09:35+00:00",
    "headline": "A Look At Danaher (DHR) Valuation After Earnings And 2026 Targets Reaffirm Growth Story",
    "summary": "Danaher (DHR) is back in focus after its latest earnings, where revenue met Wall Street expectations and bioprocessing plus diagnostics helped support the outlook alongside new 2026 growth and profit targets. See our latest analysis for Danaher. Danaher shares have been choppy around the latest earnings release, with a recent 1 day share price return of 1.35% and a 30 day share price return showing a 6.73% decline, while the 1 year total shareholder return of 4.14% points to relatively modest...",
    "url": "https://finance.yahoo.com/news/look-danaher-dhr-valuation-earnings-150935803.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "a5d01fa5-764f-3453-8726-28b93fe05e62",
      "content": {
        "id": "a5d01fa5-764f-3453-8726-28b93fe05e62",
        "contentType": "STORY",
        "title": "A Look At Danaher (DHR) Valuation After Earnings And 2026 Targets Reaffirm Growth Story",
        "description": "",
        "summary": "Danaher (DHR) is back in focus after its latest earnings, where revenue met Wall Street expectations and bioprocessing plus diagnostics helped support the outlook alongside new 2026 growth and profit targets. See our latest analysis for Danaher. Danaher shares have been choppy around the latest earnings release, with a recent 1 day share price return of 1.35% and a 30 day share price return showing a 6.73% decline, while the 1 year total shareholder return of 4.14% points to relatively modest...",
        "pubDate": "2026-02-05T15:09:35Z",
        "displayTime": "2026-02-05T15:09:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/cd882777b6cc15b2360b466e842457e4",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rZdbQ9ZLZdOFwFfglEWXFw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/cd882777b6cc15b2360b466e842457e4.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s_CYjA6sgJiGa0tfTcFO6w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/cd882777b6cc15b2360b466e842457e4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/look-danaher-dhr-valuation-earnings-150935803.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/look-danaher-dhr-valuation-earnings-150935803.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T15:09:00+00:00",
    "headline": "Cleveland Diagnostics Names Jack Kenny as Chairman of the Board",
    "summary": "CLEVELAND, February 05, 2026--Cleveland Diagnostics Names Jack Kenny as Chairman of the Board",
    "url": "https://finance.yahoo.com/news/cleveland-diagnostics-names-jack-kenny-150900035.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "6f7e0f6e-0e77-31ae-b4ec-251a045cdcc4",
      "content": {
        "id": "6f7e0f6e-0e77-31ae-b4ec-251a045cdcc4",
        "contentType": "STORY",
        "title": "Cleveland Diagnostics Names Jack Kenny as Chairman of the Board",
        "description": "",
        "summary": "CLEVELAND, February 05, 2026--Cleveland Diagnostics Names Jack Kenny as Chairman of the Board",
        "pubDate": "2026-02-05T15:09:00Z",
        "displayTime": "2026-02-05T15:09:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/d4fc80c91208a724496e5c387d2ea4dc",
          "originalWidth": 650,
          "originalHeight": 231,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sYFl1cxUXpptDYXVJ118cw--~B/aD0yMzE7dz02NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/d4fc80c91208a724496e5c387d2ea4dc.cf.webp",
              "width": 650,
              "height": 231,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HwfStAvrDTXzzf6jZOgmdg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/d4fc80c91208a724496e5c387d2ea4dc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cleveland-diagnostics-names-jack-kenny-150900035.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cleveland-diagnostics-names-jack-kenny-150900035.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            },
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]